Results of a single-arm pilot study of 32P microparticles in unresectable locally advanced pancreatic adenocarcinoma with gemcitabine/nab-paclitaxel or FOLFIRINOX chemotherapy

ESMO Open ◽

10.1016/j.esmoop.2021.100356 ◽

2022 ◽

Vol 7 (1) ◽

pp. 100356

Author(s):

P.J. Ross ◽

H.S. Wasan ◽

D. Croagh ◽

M. Nikfarjam ◽

N. Nguyen ◽

...

Keyword(s):

Pilot Study ◽

Pancreatic Adenocarcinoma ◽

Locally Advanced ◽

Locally Advanced Pancreatic Adenocarcinoma ◽

Advanced Pancreatic Adenocarcinoma

Download Full-text

Su1146 PANCO: AN OPEN-LABEL, SINGLE-ARM PILOT STUDY OF PHOSPHORUS-32 (ONCOSIL™) MICROPARTICLES IN PATIENTS WITH UNRESECTABLE LOCALLY ADVANCED PANCREATIC ADENOCARCINOMA (LAPC) IN COMBINATION WITH FOLFIRINOX OR GEMCITABINE + NAB-PACLITAXEL (GNP) CHEMOTHERAPIES

Gastroenterology ◽

10.1016/s0016-5085(20)31996-x ◽

2020 ◽

Vol 158 (6) ◽

pp. S-523-S-524

Author(s):

Paul J. Ross ◽

Daniel Croagh ◽

Morteza Aghmesheh ◽

Adnan Nagrial ◽

Vu Kwan ◽

...

Keyword(s):

Pilot Study ◽

Pancreatic Adenocarcinoma ◽

Locally Advanced ◽

Locally Advanced Pancreatic Adenocarcinoma ◽

Advanced Pancreatic Adenocarcinoma

Download Full-text

PanCO: design of an open label, single arm pilot study of OncoSil™ in subjects with unresectable locally advanced pancreatic adenocarcinoma, given in combination with standard chemotherapy

Annals of Oncology ◽

10.1093/annonc/mdx261.227 ◽

2017 ◽

Vol 28 ◽

pp. iii81 ◽

Author(s):

Paul J. Ross ◽

Michelle Bradney ◽

Jeremy Simpson

Keyword(s):

Pilot Study ◽

Pancreatic Adenocarcinoma ◽

Locally Advanced ◽

Standard Chemotherapy ◽

Locally Advanced Pancreatic Adenocarcinoma ◽

Advanced Pancreatic Adenocarcinoma

Download Full-text

PanCO: An open-label, single-arm pilot study of Oncosil™ in patients with unresectable locally advanced pancreatic adenocarcinoma in combination with FOLFIRINOX or gemcitabine+nab-paclitaxel chemotherapies

Annals of Oncology ◽

10.1093/annonc/mdy151.140 ◽

2018 ◽

Vol 29 ◽

pp. v39

Author(s):

M. Harris ◽

D. Croagh ◽

M. Aghmesheh ◽

A. Nagrial ◽

N. Nguyen ◽

...

Keyword(s):

Pilot Study ◽

Pancreatic Adenocarcinoma ◽

Locally Advanced ◽

Locally Advanced Pancreatic Adenocarcinoma ◽

Advanced Pancreatic Adenocarcinoma

Download Full-text

Mo1304 PANCO: AN OPEN LABEL, SINGLE ARM PILOT STUDY OF ONCOSIL™, ADMINISTERED TO STUDY PARTICIPANTS WITH UNRESECTABLE LOCALLY ADVANCED PANCREATIC ADENOCARCINOMA, GIVEN IN COMBINATION WITH FOLFIRINOX OR GEMCITABINE+NAB-PACLITAXEL CHEMOTHERAPIES

Gastrointestinal Endoscopy ◽

10.1016/j.gie.2018.04.1954 ◽

2018 ◽

Vol 87 (6) ◽

pp. AB437

Author(s):

Daniel Croagh ◽

Marion Harris ◽

Morteza Aghmesheh ◽

David B. Williams ◽

Paul J. Ross ◽

...

Keyword(s):

Pilot Study ◽

Pancreatic Adenocarcinoma ◽

Locally Advanced ◽

Locally Advanced Pancreatic Adenocarcinoma ◽

Study Participants ◽

Advanced Pancreatic Adenocarcinoma

Download Full-text

O-1 PanCO: Updated results of an open-label, single-arm pilot study of OncoSil P-32 microparticles in unresectable locally advanced pancreatic adenocarcinoma (LAPC) with gemcitabine + nab-paclitaxel or FOLFIRINOX chemotherapy

Annals of Oncology ◽

10.1016/j.annonc.2020.04.054 ◽

2020 ◽

Vol 31 ◽

pp. 232

Author(s):

P. Ross ◽

A. Hendlisz ◽

T. Ajithkumar ◽

C. Iwuji ◽

M. Harris ◽

...

Keyword(s):

Pilot Study ◽

Pancreatic Adenocarcinoma ◽

Locally Advanced ◽

Locally Advanced Pancreatic Adenocarcinoma ◽

Advanced Pancreatic Adenocarcinoma

Download Full-text

COMPARISON OF DIAGNOSTIC GAINS BY NEXT-GENERATION PROFILING, CONVENTIONAL CYTOLOGY AND HISTOLOGY IN PATIENTS WITH LOCALLY ADVANCED PANCREATIC ADENOCARCINOMA FOLLOWING EUS-GUIDED BIOPSY

10.1055/s-0040-1704665 ◽

2020 ◽

Author(s):

S Carrara ◽

L Laghi ◽

S Giulia ◽

M Di Leo ◽

L Lamonaca ◽

...

Keyword(s):

Pancreatic Adenocarcinoma ◽

Locally Advanced ◽

Next Generation ◽

Conventional Cytology ◽

Guided Biopsy ◽

Locally Advanced Pancreatic Adenocarcinoma ◽

Advanced Pancreatic Adenocarcinoma

Download Full-text

P-163 Real-world outcomes of cisplatin, capecitabine and gemcitabine with either epirubicin (PEXG) or docetaxel (PDXG) as first-line palliative treatment in metastatic or unresectable locally advanced pancreatic adenocarcinoma

Annals of Oncology ◽

10.1016/j.annonc.2021.05.218 ◽

2021 ◽

Vol 32 ◽

pp. S155

Author(s):

N. Waldron ◽

N. Hitchen ◽

S. Deva ◽

G. Rivalland ◽

M. Findlay ◽

...

Keyword(s):

Pancreatic Adenocarcinoma ◽

Palliative Treatment ◽

Locally Advanced ◽

Locally Advanced Pancreatic Adenocarcinoma ◽

Advanced Pancreatic Adenocarcinoma

Download Full-text

Long-term outcomes of induction chemotherapy and neoadjuvant stereotactic body radiotherapy for borderline resectable and locally advanced pancreatic adenocarcinoma

Acta Oncologica ◽

10.3109/0284186x.2015.1004367 ◽

2015 ◽

Vol 54 (7) ◽

pp. 979-985 ◽

Author(s):

Eric A. Mellon ◽

Sarah E. Hoffe ◽

Gregory M. Springett ◽

Jessica M. Frakes ◽

Tobin J. Strom ◽

...

Keyword(s):

Pancreatic Adenocarcinoma ◽

Induction Chemotherapy ◽

Stereotactic Body Radiotherapy ◽

Locally Advanced ◽

Long Term Outcomes ◽

Borderline Resectable ◽

Locally Advanced Pancreatic Adenocarcinoma ◽

Advanced Pancreatic Adenocarcinoma

Download Full-text

Neoadjuvant gemcitabine, S-1, and intensity-modulated radiotherapy (IMRT) in patients with locally advanced pancreatic adenocarcinoma (PDAC)

Pancreatology ◽

10.1016/j.pan.2016.06.172 ◽

2016 ◽

Vol 16 (4) ◽

pp. S46

Author(s):

Yuichi Hosokawa ◽

Yuichi Nagakawa ◽

Yatsuka Sahara ◽

Chie Takishita ◽

Tetsushi Nakajima ◽

...

Keyword(s):

Pancreatic Adenocarcinoma ◽

Locally Advanced ◽

Intensity Modulated Radiotherapy ◽

Intensity Modulated ◽

Locally Advanced Pancreatic Adenocarcinoma ◽

Advanced Pancreatic Adenocarcinoma

Download Full-text

Dose-volume Analysis of Predictors for Gastrointestinal Toxicity after Radiotherapy and Concurrent Full-dose Gemcitabine for Locally Advanced Pancreatic Adenocarcinoma

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2011.06.1676 ◽

2011 ◽

Vol 81 (2) ◽

pp. S169-S170 ◽

Author(s):

J. Huang ◽

J.M. Roberson ◽

H. Ye ◽

D. Yan

Keyword(s):

Pancreatic Adenocarcinoma ◽

Locally Advanced ◽

Gastrointestinal Toxicity ◽

Volume Analysis ◽

Full Dose ◽

Dose Volume ◽

Locally Advanced Pancreatic Adenocarcinoma ◽

Advanced Pancreatic Adenocarcinoma

Download Full-text